WealthPLAN Partners’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,017
Closed -$168K 1186
2023
Q2
$168K Sell
2,017
-85
-4% -$7.07K 0.02% 319
2023
Q1
$160K Buy
+2,102
New +$160K 0.02% 346
2022
Q1
$227K Sell
3,071
-562
-15% -$41.5K 0.02% 361
2021
Q4
$339K Sell
3,633
-8,116
-69% -$757K 0.02% 301
2021
Q3
$1.35M Buy
11,749
+187
+2% +$21.5K 0.09% 142
2021
Q2
$1.45M Sell
11,562
-52
-0.4% -$6.54K 0.1% 128
2021
Q1
$1.51M Sell
11,614
-139
-1% -$18K 0.12% 118
2020
Q4
$1.91M Buy
11,753
+507
+5% +$82.5K 0.16% 100
2020
Q3
$1.39M Buy
11,246
+314
+3% +$38.8K 0.14% 104
2020
Q2
$1.22M Buy
10,932
+132
+1% +$14.7K 0.13% 106
2020
Q1
$1.07M Buy
10,800
+12
+0.1% +$1.19K 0.14% 101
2019
Q4
$1.06M Buy
10,788
+40
+0.4% +$3.92K 0.12% 105
2019
Q3
$905K Sell
10,748
-238
-2% -$20K 0.12% 112
2019
Q2
$919K Sell
10,986
-37
-0.3% -$3.1K 0.14% 111
2019
Q1
$909K Sell
11,023
-257
-2% -$21.2K 0.14% 113
2018
Q4
$977K Sell
11,280
-1,065
-9% -$92.2K 0.16% 103
2018
Q3
$944K Buy
12,345
+296
+2% +$22.6K 0.17% 99
2018
Q2
$1.15M Buy
12,049
+560
+5% +$53.3K 0.24% 93
2018
Q1
$1.01M Buy
11,489
+344
+3% +$30.2K 0.22% 94
2017
Q4
$946K Buy
11,145
+54
+0.5% +$4.58K 0.25% 93
2017
Q3
$960K Buy
11,091
+564
+5% +$48.8K 0.27% 76
2017
Q2
$812K Buy
10,527
+9,655
+1,107% +$745K 0.23% 80
2017
Q1
$58.4K Buy
+872
New +$58.4K 0.2% 98
2016
Q3
$689K Sell
10,488
-753
-7% -$49.4K 0.22% 66
2016
Q2
$603K Buy
+11,241
New +$603K 0.08% 169
2015
Q4
$914K Buy
+13,015
New +$914K 0.15% 108
2015
Q2
Sell
-13,260
Closed -$997K 515
2015
Q1
$997K Buy
+13,260
New +$997K 0.46% 44